ARCHIVES

Second-Generation CML Drugs Show Promise For Frontline

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

November 16, 2012

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

Breast Cancer Rates Decline Most for Affluent White Women

February 26, 2010

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

$293 Million NCI Budget Cut To Drop Grant Success Rate

May 10, 2013

Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.

December 15, 2000